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For many patients with advanced chronic kidney disease (CKD) requiring renal 
replacement therapy (RRT), particularly frail patients or with significant comorbid 
disease burden, haemodialysis remains the default treatment option. Kidney 
transplantation and peritoneal dialysis provide alternative modalities of RRT, 
respectively offering differing benefits and potential hazards; whilst some patients 
may consider they would prefer conservative management of advanced kidney 
disease.  
Conventionally, once established on haemodialysis, therapy revolves around 
established, auditable treatment targets such as dialysis adequacy, haemoglobin, 
serum phosphate and haemodialysis access which are usually associated with better 
outcomes. For example, considering adequacy of haemodialysis, achievement of a 
urea-reduction ratio of >67% has been associated with a reduced risk of death by 
26% [1].  This concept of guideline directed therapy to improve specific outcomes is 
not new. Nephrologists have applied this mantra for decades and generally, this 
approach has improved patient outcomes, when one considers the expansion of 
haemodialysis programmes over the past three decades, to take on more elderly, 
frail and comorbid patients. 
However important, extending life may not necessarily be the outcome all patients 
wish, some of whom may opt for quality over quantity of life.  It is only in the last few 
years that focus has turned towards patient reported outcomes in renal medicine, 
focussing on symptoms, mood and physical independence. Efforts are being made 
by renal registries to routinely collect these data [2].   In a condition associated with 
‘accelerated aging’ [3], nephrologists must understand the natural history of patient 
reported outcomes in order to improve patient care. Physical fitness is lower in 
advanced CKD compared to healthy age-matched individuals. Underpinning the 
natural history of physical function in haemodialysis patients - who face at least 12 
hours per week of enforced sedentariness - is essential to support intervention to 
improve both quality and quantity of life.  
In their paper [4] Van Loon et al study the trajectory of physical function in a 
haemodialysis population from 2004-2009, with particular focus on effect of age on 
physical function. They analysed data collected originally collected as part of the 
CONTRAST study, a randomised control trial assessing the effect of haemodialysis 
versus haemodiafiltration on cardiovascular health and all-cause mortality in a 
multicentre study involving North American and European participants. Using a 
validated tool (KDQOL-SF) they assessed self-reported physical ability at baseline 
and annually during follow-up.  Participants’ physical function status was divided into 
tertiles of low, intermediate and poor physical function to describe baseline 
characteristics. For analysis, participants were divided into groups based on age; 
<65, 65-74 and ≥75 years. At 2 years the composite of a pre-determined decline in 
performance score or remaining in the ‘poor’ category were defined as a poor-
outcome. A logistic regression model was applied to determine factors associated 
with this poor outcome and baseline demographics.  
Baseline data were available on almost 700 participants, with a mean age of 64 
years.  At baseline, there was a clear difference in reported physical function by each 
age group with ‘good’ function being present in only 41.7, 28.7 and 21.8% of those 
aged <65, 65-74 and ≥75 years respectively.  Although striking, these findings are in 
keeping with known effects of CKD, a wasting disease associated with 
sarcopenia[5]. More worryingly, they describe baseline physical function group as 
predictive of survival with mortality rates of 14,19 and 48% at 2 years for good, 
intermediate and low baseline. In addition to their high mortality rate, a further 24% 
of those with poor baseline physical function had a poor composite outcome (9% 
stagnated in the poor category and a further 15% declined). In those aged ≥65years 
who began in the good or intermediate groups the most frequent outcome was 
decline in physical function score.   
Previous work has shown that initiating dialysis is linked with substantial and 
sustained decline in function status [6] and that lower functional status is associated 
with higher mortality [7]. Both findings provide clinicians with useful information when 
discussing initiation of dialysis with patients. However, there are difference in study 
methodology between those and this current report. For instance, the former study 
examined only nursing home residents with a mean age of 73 years and the latter, it 
must be remembered that initiation of dialysis not only increases exposure to 
medical intervention and nosocomial infection but has an increased risk of 
cardiovascular events[8], which a less physically active person may not tolerate, 
leading to higher mortality rates at initiation. Whilst viewed as a limitation by the 
authors, the finding of progressive physical decline – faster than that expected in the 
general population – in the surviving prevalent population is significant and 
applicable to current dialysis care. A further limitation offered by the authors is the 
use of patients in a clinical trial to observe the trajectory of physical decline and use 
of self-reported questionnaires. The self-inclusion into such a study, is likely to omit 
those most frail. This only supports the likelihood that their results underestimate the 
degree of low physical function in the prevalent dialysis population and calls for 
development of urgent interventions. In their logistic regression model, they identify 
increasing age and lower serum albumin as predictors of poor outcome. They 
accurately, albeit unfortunately, acknowledge that neither are reversible factors.   
However, there remains hope. The results of a recent multicentre randomised control 
trial of a simple exercise program managed by dialysis staff[9] demonstrated an 
improvement in physical function in addition to improvement in quality of life scores. 
Implementing a simple exercise ‘prescription’ to this captive audience is a 
commendable idea. At present, it is yet to be seen if a mortality benefit can be 
gained.  
Van Loon et al have shown a rapid decline in physical function as the natural 
trajectory of prevalent dialysis patients, with higher mortality rates in those with low 
physical function at baseline, identifying those aged ≥65 years as the at-risk group.   
As renal registries begin collecting quality of life data, it seems logical to develop 
evidence based interventions to improve physical function, with the goal of improving 
quality and, perhaps in time, quantity of life.  
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